Document is current
Any future updates will be listed below
-
Authors
Mosquera-Lopez, Clara https://orcid.org/0000-0003-1586-2490
Wilson, Leah M. https://orcid.org/0000-0003-3634-481X
El Youssef, Joseph
Hilts, Wade
Leitschuh, Joseph https://orcid.org/0000-0001-5434-9361
Branigan, Deborah https://orcid.org/0000-0003-2822-587X
Gabo, Virginia https://orcid.org/0000-0001-6256-9938
Eom, Jae H. https://orcid.org/0000-0002-0319-255X
Castle, Jessica R.
Jacobs, Peter G.
- License Information
-
More Information
Article History
Received: 15 June 2022
Accepted: 16 February 2023
First Online: 13 March 2023
Competing interests
: P.G.J. and J.R.C. have a financial interest in Pacific Diabetes Technologies Inc., a company that may have a commercial interest in the results of this research and technology. J.R.C. also reports advisory board participation for Zealand Pharma, Novo Nordisk, Insulet, and AstraZeneca, and her institution has received research funding from Dexcom. For all other authors, no competing interests exist.
